Teladoc Health, Inc.·4

Sep 4, 4:11 PM ET

Waters Michael Willem 4

4 · Teladoc Health, Inc. · Filed Sep 4, 2024

Insider Transaction Report

Form 4
Period: 2024-08-30
Waters Michael Willem
CHIEF OPERATING OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-08-30+6,20082,527 total
  • Sale

    Common Stock

    2024-09-03$7.16/sh4,218$30,21878,309 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-08-306,20037,204 total
    Common Stock (6,200 underlying)
  • Exercise/Conversion

    Common Stock

    2024-08-30+2,11376,327 total
  • Exercise/Conversion

    Performance Stock Units

    2024-08-302,11312,679 total
    Common Stock (2,113 underlying)
Footnotes (5)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F5]On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Documents

1 file
  • 4
    wk-form4_1725480704.xmlPrimary

    FORM 4